|
Re: Zenith Presentation at AACR Meeting April 10-15
|
1
|
Zenith Epigenetics
|
Apr 12, 2021 10:46AM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
2
|
Zenith Epigenetics
|
Apr 12, 2021 10:03AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
6
|
Resverlogix Corp.
|
Apr 12, 2021 08:44AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
5
|
Resverlogix Corp.
|
Apr 12, 2021 08:34AM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
3
|
Zenith Epigenetics
|
Apr 11, 2021 02:24PM
|
|
Re: Insider Transactions - RSU/Deferred Shares
|
1
|
Resverlogix Corp.
|
Apr 11, 2021 01:24PM
|
|
This late June meeting, warrants about to expire???
|
4
|
Resverlogix Corp.
|
Apr 09, 2021 11:34AM
|
|
Re: GV on stock house
|
5
|
Resverlogix Corp.
|
Apr 08, 2021 01:47PM
|
|
GV on stock house
|
6
|
Resverlogix Corp.
|
Apr 08, 2021 11:18AM
|
|
Re: BOOM there it is
|
13
|
Resverlogix Corp.
|
Apr 08, 2021 10:51AM
|
|
Re: otc zen
|
2
|
Zenith Epigenetics
|
Apr 06, 2021 11:09PM
|
|
Re: otc zen
|
|
Zenith Epigenetics
|
Apr 06, 2021 07:31PM
|
|
otc zen
|
|
Zenith Epigenetics
|
Apr 06, 2021 06:17PM
|
|
well
|
5
|
Resverlogix Corp.
|
Apr 05, 2021 09:52PM
|
|
Re: Management
|
2
|
Resverlogix Corp.
|
Apr 05, 2021 09:58AM
|
|
Re: Year-end financials
|
3
|
Resverlogix Corp.
|
Apr 01, 2021 02:53PM
|
|
Re: the significance of the March 29/2021 announcement
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2021 03:52PM
|
|
mean while hepa’s SP continues downward nearing its 52week low...
|
4
|
Resverlogix Corp.
|
Mar 31, 2021 02:24PM
|
|
Re: FDA busts Merck's Keytruda in triple-negative breast cancer with a CRL — not unexpected given its disastrous adcomm
|
1
|
Zenith Epigenetics
|
Mar 30, 2021 04:41PM
|
|
Re: FDA busts Merck's Keytruda in triple-negative breast cancer with a CRL — not unexpected given its disastrous adcomm
|
1
|
Zenith Epigenetics
|
Mar 30, 2021 02:46PM
|
